Heart Doc VIP with Dr. Joel Kahn Episode 482: Why the Framingham Heart Study Still Matters
9 snips
Feb 17, 2026 A deep dive into why a decades‑long heart study reshaped how we think about risk factors. Short rundowns of magnesium and berberine trials are covered. Practical debate on low‑carb versus low‑fat diet quality. Concerns about long‑term proton pump inhibitor use are raised. Newer therapies like EECP and ezetimibe, plus a surprising CT angiogram case, are discussed.
AI Snips
Chapters
Transcript
Episode notes
Prefer Absorbable Magnesium Forms
- Try a well-absorbed magnesium formulation to improve sleep, stress, muscle aches, and fasting glucose control.
- Prefer mixed forms like citrate, bisglycinate, and taurate over magnesium oxide for better uptake and tolerance.
Berberine Lowers LDL but Not Liver Fat Here
- Randomized trials show berberine lowers LDL and inflammation but may not reduce liver fat in short trials.
- Effectiveness can depend on duration, population, and endpoints measured.
Quality Trumps Low-Carb vs Low-Fat
- Diet quality, not just macronutrient ratio, determines heart-disease risk across low-fat and low-carb patterns.
- Healthy versions of either approach (plant fats, nuts, veggies) associate with better lipids and lower inflammation.